VBIO PE Ratio & Valuation, Is VBIO Overvalued

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for VBIO competitors is 0.26, providing a benchmark for relative valuation. Valion Bio Inc Corp (VBIO.O) exhibits a P/S ratio of --, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of VBIO increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of VBIO in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is VBIO currently overvalued or undervalued?

Valion Bio Inc (VBIO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of --. The fair price of Valion Bio Inc (VBIO) is between to according to relative valuation method.

What is Valion Bio Inc (VBIO) fair value?

VBIO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Valion Bio Inc (VBIO) is between to according to relative valuation method.

How does VBIO's valuation metrics compare to the industry average?

The average P/S ratio for VBIO's competitors is 0.26, providing a benchmark for relative valuation. Valion Bio Inc Corp (VBIO) exhibits a P/S ratio of --, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for Valion Bio Inc (VBIO) as of May 10 2026?

As of May 10 2026, Valion Bio Inc (VBIO) has a P/B ratio of 0.19. This indicates that the market values VBIO at 0.19 times its book value.

What is the current FCF Yield for Valion Bio Inc (VBIO) as of May 10 2026?

As of May 10 2026, Valion Bio Inc (VBIO) has a FCF Yield of -141.18%. This means that for every dollar of Valion Bio Inc's market capitalization, the company generates -141.18 cents in free cash flow.

What is the current Forward P/E ratio for Valion Bio Inc (VBIO) as of May 10 2026?

As of May 10 2026, Valion Bio Inc (VBIO) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of Valion Bio Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Valion Bio Inc (VBIO) as of May 10 2026?

As of May 10 2026, Valion Bio Inc (VBIO) has a Forward P/S ratio of 0.00. This means the market is valuing VBIO at $0.00 for every dollar of expected revenue over the next 12 months.

VBIO Valuation